Effect of erythro-9-(2-hydroxy-3-nonyl) adenine on purine and pyrimidine metabolism in the human peripheral lymphocyte during the early phases of phytohemagglutinin-mediated blastogenesis.
D000225:Adenine / Q000031:analogs & derivatives* / Q000494:pharmacology; D058892:Adenosine Deaminase Inhibitors; D000244:Adenosine Diphosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006148:Guanine Deaminase / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000378:metabolism*; D009700:Nucleoside Deaminases / Q000037:antagonists & inhibitors*; D010835:Phytohemagglutinins / Q000494:pharmacology*; D011687:Purines / Q000378:metabolism*; D011743:Pyrimidines / Q000378:metabolism*
D058892:Adenosine Deaminase Inhibitors; D010835:Phytohemagglutinins; D011687:Purines; D011743:Pyrimidines; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D009700:Nucleoside Deaminases; D006148:Guanine Deaminase; D005947:Glucose; D000225:Adenine